Cancer

UnitedHealth Group Covers Shield Blood Test for Colorectal Cancer Screening

The Shield test is now available to eligible members aged 45 and older, expanding access to screening options for colorectal cancer.

Cancer

New Clinical Guidelines Recommend Molecular Testing for Bladder Cancer

The NCCN has updated its bladder cancer guidelines to include FDA-approved ctDNA-based MRD testing for post-surgical risk assessment and adjuvant immunotherapy decisions in muscle-invasive bladder cancer.

Cancer

Early Lung Cancer Blood Test Completes US Laboratory Validation

The CIZ1B biomarker assay is designed to complement LDCT screening by helping assess lung cancer risk and clarify indeterminate findings.

Gene Test Identifies Breast Cancer Patients Who Can Safely Skip Chemotherapy

Jun 9, 2026 | Breast

Findings from the OPTIMA trial show that the Prosigna test identifies patients who can safely skip chemotherapy and use hormone therapy alone.

Urine Test Reduced Unnecessary Prostate Biopsies by 64%, Study Finds

Jun 8, 2026 | Prostate

Researchers reported that the test reduced unnecessary biopsies by up to 64% without compromising detection of aggressive prostate cancers.

Labcorp Expands DPYD Test to Identify Chemotherapy Toxicity Risk

Jun 8, 2026 | Cancer, Company News, Molecular Diagnostics

The updated test includes additional DPYD variants recommended by the Association for Molecular Pathology to help identify patients who may be at risk for severe chemotherapy side effects.

Blood Test Boosts Lung Cancer Screening Participation

Jun 8, 2026 | Lung Cancer, Molecular Diagnostics

New clinical utility data showed that offering a blood-based lung cancer test increased screening participation compared with low-dose CT screening alone.

Study Shows Blood Test Predicts Breast Cancer Recurrence Years Before Clinical Symptoms

Jun 5, 2026 | Breast, Molecular Diagnostics

Monitoring circulating tumor DNA dynamics outperformed standard markers for predicting survival and relapse in early-stage patients.

Blood Test for Colon Cancer Improves Chemotherapy Decisions, Study Finds

Jun 5, 2026 | Colorectal, Molecular Diagnostics

The study demonstrated that patients who test positive for ctDNA “actually benefit from chemotherapy.”

Study: New Mapping Method Improves Detection of Leukemia Abnormalities

Jun 4, 2026 | Cancer, Leukemia, Molecular Diagnostics

Research shows optical genome mapping identifies genomic changes in nearly 98% of T-cell acute lymphoblastic leukemia cases compared to 55% with traditional analysis.